Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.41 USD | +3.02% | +11.80% | +191.45% |
04-26 | Maia Biotechnology Insider Bought Shares Worth $299,409, According to a Recent SEC Filing | MT |
04-22 | MAIA Biotechnology, Inc. announced that it expects to receive $0.664994 million in funding | CI |
Sales 2024 * | - | Sales 2025 * | 35.39M 48.21M | Capitalization | 70.18M 95.62M |
---|---|---|---|---|---|
Net income 2024 * | -33M -44.96M | Net income 2025 * | -34M -46.32M | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 1.98 x |
P/E ratio 2024 * |
-2.15
x | P/E ratio 2025 * |
-
| Employees | 13 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 77.88% |
1 day | +3.02% | ||
1 week | +11.80% | ||
Current month | +16.38% | ||
1 month | +58.60% | ||
3 months | +140.14% | ||
6 months | +190.21% | ||
Current year | +191.45% |
Managers | Title | Age | Since |
---|---|---|---|
Vlad Vitoc
CEO | Chief Executive Officer | 54 | 18-08-02 |
Director of Finance/CFO | 49 | 23-08-31 | |
Sergei Gryaznov
CTO | Chief Tech/Sci/R&D Officer | 64 | 19-11-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 57 | 20-03-31 | |
Ramiro Guerrero
BRD | Director/Board Member | 59 | - |
Steven Chaouki
BRD | Director/Board Member | 51 | 21-09-27 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-20 | 3.41 | +3.02% | 551,404 |
24-05-17 | 3.31 | +6.09% | 424,011 |
24-05-16 | 3.12 | +8.71% | 334,993 |
24-05-15 | 2.87 | +1.06% | 87,620 |
24-05-14 | 2.84 | -6.89% | 149,641 |
Delayed Quote Nyse, May 20, 2024 at 04:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+191.45% | 68.12M | |
+41.79% | 50.93B | |
-0.56% | 42.12B | |
+49.62% | 42.05B | |
-7.20% | 29.18B | |
+12.59% | 26.02B | |
-21.51% | 18.9B | |
+6.92% | 13.21B | |
+24.91% | 12.17B | |
+29.60% | 12.16B |
- Stock Market
- Equities
- MAIA Stock